TABLE 3.

Comparison of the different assays to perform immune diagnosis of TB

PeptidesTestNo. of patients positive/total no. (%)
Active TB patientsControl subjects
TST positiveTST negativeTotala
Selected RD1WBE22/27 (81)4/21 (19)0/20 (0)4/41 (10)
ELISPOT20/27 (74)3/21 (14)0/20 (0)3/41 (7)
RD1 overlappingQuantiFERON-TB-Gold24/27 (89)11/21 (52)2/20 (10)13/41 (32)
  • a Total, TST-positive and TST-negative control subjects.